Use Q4132 for Grafix Core or GrafixPL Core. Q4133 is for Grafix or Stravix Prime PL; match the product name in the record.
On this page
CMS RVU26D · Effective 2026-10-01
Q4133 Placental tissue product Medicare reimbursement rates in Oklahoma
Reports Grafix or Stravix Prime PL placental tissue by square centimeter when supplied for application to a treated wound. Compare Q4133 office and facility rates across CMS payment localities in Oklahoma.
Amounts below use the non-QP conversion factor for participating physicians. These are base physician payments before claim-level adjustments, not patient costs or total hospital charges.
What does Medicare pay for Q4133 in Oklahoma?
Oklahoma has 1 payment locality in this comparison. Use the service location to choose the applicable amount. These are the supported base rates for the payment area shown below, using the same CMS release.
Office / nonfacility
$113.64
1 of 1 localities have a supported rate.
Payment area: Oklahoma
One mapped payment locality.
Facility setting
No supported rate
These are locality ranges, not averages or address-specific quotes. A facility-setting amount covers the physician service; it does not include a hospital’s separate bill. Choose a locality below to inspect its calculation, compare other payment areas, or price a percentage of Medicare.
Wound care biologics
About Q4133: Grafix and Stravix Prime PL tissue
Reports Grafix or Stravix Prime PL placental tissue by square centimeter when supplied for application to a treated wound.
Q4133 identifies Grafix or Stravix Prime PL, placental tissue products used as wound coverings in wound care. Clinicians such as podiatrists, surgeons, and wound-care practitioners may use these products when treating wounds including diabetic foot ulcers and venous leg ulcers. The code represents the product, not the work of assessing or preparing the wound or applying the tissue.
Report the product by the square centimeter and pair it with the applicable primary wound or skin-substitute application procedure. The record should identify the product used and support the quantity reported, such as the treated wound area and amount applied. CMS classifies Q4133 as an add-on paid within the primary procedure’s global period. It is also technical-component-only; a separate code covers interpretation.
CMS billing rules for Q4133
- Global period
- Add-on code: billed only together with a primary procedure and paid within that procedure's global period.
- Professional and technical components
- Technical-component-only code: a separate code covers interpretation.
Where the value comes from
- Work RVU0.00 · 0%
- Practice expense (office) RVU3.81 · 100%
- Malpractice RVU0.00 · 0%
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
Q4133 compared with similar codes
Office rates for Oklahoma, from the same CMS release.
Q4121 identifies TheraSkin, not Grafix or Stravix Prime PL. These codes distinguish the product supplied, rather than the wound site.
Q4124 identifies Oasis tri-layer wound matrix. Use Q4133 when the documented product is Grafix or Stravix Prime PL.
Compare Q4133 by payment locality
Find the payment area for your service address, then open its rate page for calculation inputs, release history and the percentage-of-Medicare tool. A city may cross payment-area boundaries; the ZIP lookup above helps resolve the location.
1 of 1 payment localities
Oklahoma →
Office / nonfacility
$113.64
Facility
Unavailable
Need rates for a whole code list?
Fee-sheet and API access are in early access. Tell us which codes and locations your team needs.
How this local rate is calculated
Each RVU component is multiplied by its own geographic practice cost index (GPCI). The three adjusted components are added, then multiplied by the conversion factor. These are the inputs used for Q4133 in Oklahoma.
PPRRVU2026_Oct_nonQPP.csv
18,227
- Code
- Q4133
- Physician work
- 0.00
- Practice expense
- 3.81
- Malpractice
- 0.00
GPCI2026.csv
86
- Locality
- Oklahoma
- Physician work
- 1.000
- Practice expense
- 0.893
- Malpractice
- 0.777
| Component | RVU | Locality factor | Adjusted |
|---|---|---|---|
| Physician work | 0.00 | × 1.000 | 0.0000 |
| Practice expense | 3.81 | × 0.893 | 3.4023 |
| Malpractice | 0.00 | × 0.777 | 0.0000 |
| Total RVUs | 3.4023 | ||
| Conversion factor | × 33.4009 | ||
Office / nonfacility rate, Oklahoma$113.64
Explore RVUs, geographic factors and the full formula
Office / nonfacility
| Component | RVU | Local GPCI |
|---|---|---|
| Work | 0 | 1 |
| Practice expense | 3.81 | 0.893 |
| Malpractice | 0 | 0.777 |
(0 × 1 + 3.81 × 0.893 + 0 × 0.777) × $33.4009 = $113.64
The office and facility calculations use their respective practice-expense RVUs. The facility amount here is the physician fee, not a separate hospital or facility bill.
Q4133 billing questions
How is Q4133 different from Q4132?
Q4133 identifies Grafix or Stravix Prime PL. Q4132 identifies Grafix Core or GrafixPL Core, so select the code that matches the product documented.
Can Q4133 be billed by itself?
No. CMS identifies it as an add-on code, so report it with a primary procedure. Payment is within that procedure’s global period.
How many units should be reported?
The code is reported per square centimeter. Document the product quantity used and the wound area treated to support the units.
Does Q4133 include the wound application procedure?
No. Q4133 identifies the product; report the applicable primary procedure for the wound or skin-substitute application separately.
What does the technical-component designation mean for Q4133?
CMS classifies Q4133 as technical-component-only, with a separate code covering interpretation.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense, and malpractice RVUs, adjusted by each locality’s geographic indices and the applicable conversion factor. Unavailable or separately priced services are labeled rather than assigned a made-up amount.
Source: RVU26D. Effective 2026-10-01 through the day before 2027-01-01.
